v1
Outcomes of Relapsed/Refractory Patients with IDH1/2 Mutated AML Treated with Non-Targeted Therapy: Results from the NCRI AML Trials
Identifier:nobleid.org/w1/20260515/3DF7DC0B
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/3DF7DC0B)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →